GPP
Great Point Partners’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-309,800
| Closed | -$5.22M | – | 36 |
|
|
2018
Q1 | $5.22M | Sell |
309,800
-487,731
| -61% | -$8.22M | 0.78% | 25 |
|
|
2017
Q4 | $12.1M | Buy |
797,531
+300,000
| +60% | +$4.56M | 2.07% | 21 |
|
|
2017
Q3 | $8.91M | Sell |
497,531
-1,734,707
| -78% | -$31.1M | 1.73% | 17 |
|
|
2017
Q2 | $36.4M | Hold |
2,232,238
| – | – | 6.52% | 3 |
|
|
2017
Q1 | $31.3M | Buy |
2,232,238
+222,238
| +11% | +$3.11M | 6.21% | 4 |
|
|
2016
Q4 | $32.1M | Sell |
2,010,000
-696,134
| -26% | -$11.1M | 6.59% | 3 |
|
|
2016
Q3 | $45M | Buy |
2,706,134
+376
| +0% | +$6.26K | 11.49% | 1 |
|
|
2016
Q2 | $30.3M | Sell |
2,705,758
-25,452
| -0.9% | -$285K | 8.67% | 2 |
|
|
2016
Q1 | $22.8M | Buy |
2,731,210
+631,109
| +30% | +$5.28M | 8.19% | 3 |
|
|
2015
Q4 | $19.6M | Buy |
2,100,101
+385,101
| +22% | +$3.59M | 8.2% | 4 |
|
|
2015
Q3 | $19.3M | Buy |
1,715,000
+301,401
| +21% | +$3.4M | 7.65% | 1 |
|
|
2015
Q2 | $17.9M | Buy |
1,413,599
+25,000
| +2% | +$317K | 6.99% | 3 |
|
|
2015
Q1 | $12.9M | Buy |
+1,388,599
| New | +$12.9M | 5.68% | 3 |
|